In late May of 2015 – Hong Kong hosted its third annual Asia Biotech Invest conference. The atmosphere was one of collaboration, and excitement over new opportunities. Held at the Sheraton Hotel, the two day conference and exhibition brought together over 200 attendees representing 160 companies from the life science community. Our delegates were able to learn of the latest biotech investment strategies and markets, hear from the world’s biotech innovators about their current pipelines, and form new business partnerships with Asia’s top life science investors and professionals.
This year, we introduced two very exciting areas in Asia life science investment – digital health and medical device investment, both rising quickly in popularity. Delegates were also particularly impressed with the high-level panel discussions discussing China’s healthcare investment landscape, biotech partnering and collaboration models in Asia, as well as a keynote investor panel discussing the latest biotech investment trend in the years ahead. As well as this, we welcomed 22 biotech companies from around the world to the stage to present their pipeline and investment case as short, “spotlight presentations” at various times throughout the conference.
Delegates also made full use of our 1-on-1 meeting planner, with over 200 confirmed meeting requests over the entire conference.
On behalf of Beacon Events and AusBiotech, I’d like to take this time to thank all of our sponsors and spotlight presenters, as well as our delegates for your support this year to make our event the success that it is.
So mark your calendars for May, 2016 in Hong Kong and get involved in Asia’s number one biotech investment conference.
To find out how to present your company, please get in touch with:
Tel: +613 9828 1400
|Rest of the World:
Tel: +852 9275 9765